21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co ... easing knee arthritis pain to curbing asthma. Friday's FDA approval of Zepbound for treating moderate to severe ...
The Food and Drug Administration today approved Eli Lilly’s weight-loss treatment ... Regulators can expand approval for medicines if new data shows them to be effective in other therapeutic ...